Tarceva
| Tarceva | |
|---|---|
| Term | Tarceva |
| Short definition | Tarceva - (pronounced) (tar-SEE-vuh) drug used alone to treat certain types of non-small cell lung cancer and together with gemcitabine hydrochloride to treat certain types of pancreatic cancer. It is also being studied in the treatment of other types of cancer. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
Tarceva - (pronounced) (tar-SEE-vuh) drug used alone to treat certain types of non-small cell lung cancer and together with gemcitabine hydrochloride to treat certain types of pancreatic cancer. It is also being studied in the treatment of other types of cancer. Tarceva blocks a protein called EGFR, which can help prevent cancer cells from growing. It's a type of tyrosine kinase inhibitor. Also referred to as CP-358. 774, erlotinib hydrochloride, and OSI-774
External links
- Medical encyclopedia article on Tarceva
- Wikipedia's article - Tarceva
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski